Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Castle Biosciences Inc To Acquire Cernostics Inc Call Transcript

Oct 19, 2021 / 11:30AM GMT
Release Date Price: $67.58 (+7.83%)
Operator

Hello, and welcome to the Castle Biosciences Acquisition Webcast Call. My name is Lauren, and I will be coordinating your call today. (Operator Instructions)

I will now hand you over to your host, Derek Maetzold, CEO of Castle Biosciences to begin. Derek, please go ahead.

Derek J. Maetzold
Castle Biosciences, Inc. - Founder, CEO, President & Director

Thank you, Lauren. Good morning, everybody. On the call with me this morning is Frank Stokes, Castle Biosciences Chief Financial Officer; and Mike Hoerres, Cernostics' Chief Executive Officer; and this is Derek Maetzold, the President and CEO of Castle Biosciences. We appreciate you joining our call this morning for what we find as a very exciting announcement.

We are pleased this morning to announce the signing of a definitive agreement to acquire Cernostics. Cernostics is a Pittsburgh, Pennsylvania, diagnostic laboratory that works in the field of spatial biology and biologically aware AI and machine learning. Their lead product is the TissueCypher test for use in patients diagnosed with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot